Search Results

0 results for 'Biogen'

You can use to get even better search results Biogen
October 21, 2024 | Corporate Counsel

Sage Therapeutics Axes GC After Drug-Pipeline Failures Force Cost-Cutting

Sage is lopping off one-third of its workforce after one of its experimental drugs failed to prove effective as a treatment for Parkinson's and Alzheimer's diseases.
2 minute read
October 09, 2024 | The Legal Intelligencer

Gene Therapy Researcher's Patent Dispute Cleared to Proceed Against UPenn, Program Director

The court determined it wasn't required to dismiss the case pursuant to the defendants' statute of limitations argument, as questions of fact remained regarding the parties' relationship and obligations.
5 minute read
October 04, 2024 | New York Law Journal

Lawsuit Alleging $23 Million Contract Breach Against Biogen Moves Forward

Acting Manhattan Supreme Court Justice Anar Rathod Patel last week denied a motion to dismiss from defendants Reata and Biogen, finding that fact questions remained.
3 minute read
September 26, 2024 | National Law Journal

'Unfair Business Practices'?: Lawsuits Allege Big Pharma Multiple Sclerosis Drug Monopoly

"Biogen's anticompetitive conduct, and the PBMs' participation in it, delayed and substantially diminished the sale of generic Tecfidera in the United States, and unlawfully enabled Biogen to sell Tecfidera and Vumerity at artificially inflated units and prices," according to the allegations in three complaints accusing Biogen of monopolizing the multiple sclerosis drug market.
3 minute read
February 13, 2024 | Texas Lawyer

Benefiting From Energy Work and Strategic Hiring, Vinson & Elkins Breaks Above $1B Revenue Barrier in Record Year

Despite growth in its lawyer head count and equity partner ranks, Houston-based Vinson & Elkins also improved its revenue per lawyer by 2.7% and its profits per equity partner by 3.6%.
6 minute read
December 12, 2023 | Corporate Counsel

High Interest Rates Derail Grand Plans, Make Companies Vulnerable to Failure-to-Disclose Suits

Nuclear reactor company NuScale Power's failed Idaho project has spurred at least one lawsuit so far from plaintiff attorneys who say executives' comments about the likelihood of pulling it off were overly rosy.
5 minute read
November 20, 2023 | New Jersey Law Journal

Genentech, Biogen and Hoffmann-La Roche File Lawsuit Over Planned Release of 'Copycat' of Pioneering Cancer Drug

This complaint was first surfaced by Law.com Radar.
3 minute read
October 18, 2023 | Law.com

1st Circ. OKs Class Action Claim Against Biogen Over Statement Regarding Alzheimer's Drug Dose-Response Relationship

According to the court, "some patients did better on a lower dose and others experienced the same lack of clinical benefit whether they were on the higher dose or not," and therefore, the defendants failed to disclose the subgroup data, "which would have contextualized their 'all data' claim," leading the complaint to plausibly allege that the defendants' omission misled investors.
4 minute read
September 20, 2023 | National Law Journal

Arnold & Porter Enters Boston, Attracted to 'Significant' Biopharma Presence

Firm leaders expect the five-lawyer office to grow in the coming months, as Arnold & Porter will continue to be active on the lateral market in Boston.
3 minute read
August 29, 2023 | Delaware Business Court Insider

Proposed $7.3B Acquisition of Pharma Co. Draws Shareholder Lawsuit

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read

Resources

  • Why Embracing Change Is Essential for Your Legal Department

    Brought to you by DiliTrust

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now

  • The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation

    Brought to you by Erase.com

    Download Now